UPDATE
: Monday, September 7, 2020
Home
Login
Mobile Version
All
Hospital
Pharma
Bio
Korea‘s Bio Industry
Device/ICT
Policy
People
Life science
Special
Innovation for Survival
Korea’s medical culture series
Korea’s New Candidate Drug Watch List
Special Series in Celebration of KBR's 1st Anniversary
Interview with foreign envoys
Special Series in Celebration of KBR’s 2nd Anniversary
Interview with global pharma
Special Series in Celebration of KBR’s 3rd Anniversary
Special Series in Celebration of KBR’s 4th Anniversary
ASCO 2020 Highlights
Opinion
Reporter’s Notebook
Search
트위터
페이스북
RSS
상단여백
제목보기
제목보기
제목+내용
Newly listed biotech firms perform poorly on KOSDAQ
by Nam Doo-hyun
2018-10-04 13:09
‘Samsung C&T’s value to rise on BioLogics’ increased value’
by Nam Doo-hyun
2018-10-03 10:11
More doctoral degree holders wanted at biotech ventures
by Nam Doo-hyun
2018-10-02 14:40
Which health agency had highest rise in female worker percentage?
by Nam Doo-hyun
2018-10-01 13:38
Samil shares jump on anticipation of fatty liver treatment
by Nam Doo-hyun
2018-09-28 14:21
라인
Genexine wins nod for immunotherapy trial in combo treatment
by Nam Doo-hyun
2018-09-27 11:25
Korea’s drug exports continue to rise in August
by Nam Doo-hyun
2018-09-20 14:23
‘Many Korean hospitals operating in China remain unlawful’
by Nam Doo-hyun
2018-09-20 14:22
Shares of newly listed biotech firms surge
by Nam Doo-hyun
2018-09-19 18:30
‘If you can’t avoid healthcare regulation, enjoy it’
by Nam Doo-hyun
2018-09-19 14:43
라인
‘Smart hospitals’ to reduce repetitive nursing work
by Nam Doo-hyun
2018-09-17 15:48
Nature Cell shares spike despite investment alert warning
by Nam Doo-hyun
2018-09-14 16:08
Female workforce scarce in top 15 local pharmaceuticals
by Nam Doo-hyun
2018-09-13 11:41
GC Cell shares spike on winning FDA nod for Immuncell-LC
by Nam Doo-hyun
2018-09-12 16:05
‘Xgeva reduces risk of bone problems in solid tumor patients’
by Nam Doo-hyun
2018-09-12 12:23
라인
Hepatitis C patients wait for Maviret’s arrival
by Nam Doo-hyun
2018-09-11 16:16
‘ToolGen’s KOSDAQ listing might be in peril’
by Nam Doo-hyun
2018-09-10 14:59
Opdivo-Yervoy okayed as first-line treatment for renal cell carcinoma
by Nam Doo-hyun
2018-09-06 15:02
CrystalGenomics to export novel drug Acelex to Brazil soon
by Nam Doo-hyun
2018-09-04 11:18
Korea’s drug exports to China rebound this year
by Nam Doo-hyun
2018-08-31 13:10
-
1
2
3
4
5
6
7
8
9
10
다음
-
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
176 civic groups furious over government-doctors deal
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
UBcare wins patent for tech to monitor suspected infectious diseases
SCM Lifescience punished for delaying adverse reaction report
여백
Most viewed
1
‘Cyramza helped improve gastric cancer treatment in Korea’
2
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
3
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
4
SNUBH develops AI model predicting patients at risk of cerebral aneurysm
5
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
6
LG Chem, SK Bioscience end sales partnership with Daewoong
7
UBcare wins patent for tech to monitor suspected infectious diseases
8
176 civic groups furious over government-doctors deal
9
Recovered Covid-19 patients suffer from aftereffects – for long
10
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
여백
Opinion
[Column] Correct diagnosis leads to proper treatment
[Column] How ongoing doctors’ strike is different from 20 years ago
A Korean-American Doctor asks: Is Korea truly in 2020?
여백
Back to Top